Salve Technologies


Current gene therapies are mostly limited to plasmid-based and Adeno-associated virus variants with inefficient response rates and limited use.  Better viral delivery methods would expand the available gene therapy tool kit to produce precision medicines for intractable and incurable diseases. We are building VirCAD© (Virus Computer-Aided Design), an HPC-powered, cloud-accessible, AI/ML-capable bioCAD platform to mine, design, model and simulate new viral drugs for better cell and gene therapies, vaccines, oncolytics and antibiotics.  These modalities would be useful for treating and potentially curing the many inherited and acquired genetic disorders afflicting patients due to their therapeutic specificity, efficiency and irreversibility. 

Get involved with Advanced Therapies Congress


To speak

Jessica Robinson
+44 208 164 3086



To sponsor or exhibit

Ashlea Foster
+44 208 164 3032